27 January 2015

Walgreens Flu Index™ for Week of Jan. 26, 2015

DEERFIELD, Ill., January 27, 2015 - The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that’s as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.
20 January 2015

Walgreens and Madison Dearborn Partners Announce Agreement for Walgreens Infusion Services

DEERFIELD, Ill., January 20, 2015 - Walgreen Co., a wholly owned subsidiary of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), today announced that it has signed a definitive agreement with Madison Dearborn Partners (MDP), a leading private equity firm based in Chicago, under which MDP will acquire a majority interest in Walgreens Infusion Services.
20 January 2015

Walgreens Flu Index™ for Week of Jan. 19, 2015

DEERFIELD, Ill., January 20, 2015 - The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that’s as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.
15 January 2015

Walgreens Infusion Services Named a Limited Network Home Infusion Provider for New Continuous Intravenous Infusion Therapy BLINCYTO™ (blinatumomab) Immunotherapy

DEERFIELD, Ill., January 15, 2015 - Walgreens today announced that, effective immediately, Walgreens Infusion Services will serve as a limited network home infusion provider for BLINCYTO™ (blinatumomab), a therapy for the treatment of patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). BLINCYTO™ can now be obtained through and administered by Walgreens Infusion Services.
13 January 2015

Walgreens Unveils Well Beyond HIV™ Campaign to Celebrate People Over 50 Aging with HIV

DEERFIELD, Ill., Jan. 13, 2015 – Walgreens today announced the launch of Well Beyond HIV™, a national campaign highlighting people aging well beyond their HIV diagnosis. The centerpiece of the campaign is a traveling art exhibit, curated in collaboration with The Graying of AIDS, an independent documentary project and educational campaign. The exhibit provides a glimpse into the lives of older adults living with HIV and will make its first stop in Miami, Fla., this Saturday, Jan. 17. 
13 January 2015

Walgreens Flu Index™ for Week of Jan. 12, 2015

DEERFIELD, IL. – Jan. 13, 2015 - The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that’s as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.  
06 January 2015

Walgreens to Provide Up to 30-Day Prescription Supply at No Upfront Cost for Public Health Insurance Marketplace Enrollees Who Have Not Been Assigned an Identification Number

DEERFIELD, Ill., January 6, 2014 – As newly insured Americans begin using their 2015 benefits under the Affordable Care Act, Walgreens will again provide medication assistance to those patients who may have difficulty using their new insurance coverage. Through the end of January, patients who haven't yet received a plan identification number from their insurer or are otherwise having difficulty can bring confirmation of their Marketplace enrollment to a Walgreens pharmacy, and Walgreens will provide up to one month of a traditional, brand or generic medication at no upfront cost.
06 January 2015

Walgreens Flu Index™ for Week of Jan. 5, 2015

DEERFIELD, IL. – Jan. 6, 2015 - The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that’s as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level. 
30 December 2014

Walgreens Flu Index™ for Week of Dec. 29, 2014

DEERFIELD, Ill., December 30, 2014 - The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that’s as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.
29 December 2014

Walgreens Shareholders Approve All Proposals Related to Transaction with Alliance Boots and Holding Company Reorganization

DEERFIELD, Ill., December 29, 2014 - At a special meeting of shareholders held today, Walgreens (NYSE: WAG) (Nasdaq: WAG) shareholders voted to approve all proposals related to the company’s acquisition of the remaining 55 percent of Alliance Boots GmbH that it does not currently own and the reorganization of the company into a holding company structure. Approximately 97 percent of the votes cast were in favor of the reorganization proposal (representing approximately 73 percent of the company’s outstanding common stock as of Nov. 17, 2014, the record date for the special meeting), and approximately 97 percent of the votes cast were in favor of the share issuance proposal. The transaction will fully combine the two companies to form the first global pharmacy-led, health and wellbeing enterprise.